Development of Nasal Vaccines and the Associated Challenges

Area of Science:

• Immunology
• Vaccinology
• Microbiology

Background:

• Pathogenic microorganisms frequently infect hosts through respiratory mucosa.
• Nasal vaccination presents a viable alternative to conventional methods for combating respiratory infections.
• The intranasal route offers advantages in accessibility and ease of administration compared to injections.

Purpose of the Study:

• To summarize recent findings on strategies for developing effective nasal vaccines.
• To highlight advancements in antigen and adjuvant design for nasal vaccine optimization.
• To present nasal immunization as a promising alternative to traditional vaccines for respiratory diseases.

Main Methods:

• Review of recent scientific literature on nasal vaccine development.
• Analysis of strategies for antigen and adjuvant design and optimization.
• Evaluation of safety and efficacy data for intranasal vaccines.

Main Results:

• Nasal vaccination can induce robust mucosal and systemic immunity against respiratory pathogens.
• Optimized antigen and adjuvant strategies accelerate the induction of protective immune responses.
• Recent progress has led to efficacious nasal vaccines with improved safety profiles.

Conclusions:

• Nasal immunization is a highly promising strategy for preventing respiratory infectious diseases.
• Continued research in antigen/adjuvant design enhances the potential of nasal vaccines.
• Nasal vaccines represent an efficient and accessible alternative to conventional vaccination methods.